用羟基脲对中间型地中海贫血进行药物治疗。
Pharmacologic treatment of thalassemia intermedia with hydroxyurea.
作者信息
Hajjar F M, Pearson H A
机构信息
Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut.
出版信息
J Pediatr. 1994 Sep;125(3):490-2. doi: 10.1016/s0022-3476(05)83304-9.
PMID:7520935
Abstract
Three adult patients with beta-thalassemia intermedia were treated with hydroxyurea. Each had a significant but transient rise in total hemoglobin level associated with a variable increase in hemoglobin F.
摘要
三名中间型β地中海贫血成年患者接受了羟基脲治疗。每名患者的总血红蛋白水平均有显著但短暂的升高，同时血红蛋白F也有不同程度的增加。
Zotero 插件